Eleven Biotherapeutics reports third quarter 2017 financial results
Eleven Biotherapeutics reported net loss was $9.1 million for the 2017 third quarter versus net income of $19.5 million for the same 2016 period. Eleven did not record any revenue for 2017 third quarter versus revenue of $28.7 million for the same 2016 period. November 20, 2017